Expand DCTH Menu
DCTH MENU

DCTH Latest Press Releases

-- December 3, 2025 --

Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma Business Wire 4:01 PM

-- November 20, 2025 --

Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program Business Wire 4:01 PM

-- November 18, 2025 --

Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma Business Wire 8:00 AM

-- November 14, 2025 --

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- November 13, 2025 --

Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients Business Wire 8:30 AM

-- November 6, 2025 --

Delcath Systems to Participate in Upcoming Investor Conferences Business Wire 4:01 PM

-- November 4, 2025 --

Delcath Systems Reports Third Quarter 2025 Results and Business Highlights Business Wire 8:00 AM

-- October 21, 2025 --

Delcath Systems to Host Third Quarter 2025 Earnings Call Business Wire 8:30 AM

-- October 18, 2025 --

Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results Business Wire 4:15 PM
Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint Business Wire 4:13 PM

-- September 22, 2025 --

Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress Business Wire 4:01 PM

-- September 5, 2025 --

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM

-- August 21, 2025 --

Delcath Systems to Participate in Upcoming Investor Conferences Business Wire 8:30 AM

-- August 19, 2025 --

Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer Business Wire 8:30 AM

-- August 6, 2025 --

Delcath Systems Reports Second Quarter 2025 Results and Business Highlights Business Wire 8:00 AM

-- July 29, 2025 --

Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference Business Wire 4:01 PM

-- July 25, 2025 --

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:01 PM
Market Data Delayed 15 Minutes